IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Authors:
Preprint
- 16 January 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
IKKα has been shown to be responsible of multiple pro-tumorigenic functions and therapy resistance independent of canonical NF-κB, but its role in acquired chemotherapy resistance in breast cancer remains unclarified. In this study, we obtained pre-treatment biopsy and post-treatment mastectomy specimens from aretrospective cohort of triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy(NAC) (n = 43). Immunohistochemical methods were used to detect the expression of IKKα before and after NAC, and the relationship between IKKα and the pathologic response to NAC was examined. In addition, we developed a new ADR-resistant MDA-MB-231 cell line(MDA-MB-231/ADR) and analyzed these cells for changes in IKKα expression, the role and mechanisms of the increased IKKα in promoting drug resistance were determined in vitro and in vivo. We demonstrated that the expression of IKKα in residual TNBC tissues after chemotherapy was significantly higher than that before chemotherapy, and was positively correlated with lower pathological reaction. IKKα expression was significantly higher in ADR-resistant TNBC cells than in ADR-sensitive cells, IKKα knockdown results in apoptotic cell death of chemoresistant cells upon drug treatment. Moreover, IKKα knockdown promotes chemotherapeutic drug-induced tumor cell death in an transplanted tumor mouse model. Functionally, we demonstrated that IKKα knockdown significantly upregulated the expression of cleaved caspase 3 and Bax and inhibited the expression of Bcl-2 upon ADR treatment. Our findings highlighted that IKKα exerts an important and previously unknown role in promoting chemoresistance in TNBC, combining IKKα inhibition with chemotherapy may be an effective strategy to improve treatment outcome in chemoresistant TNBC patients.Keywords
All Related Versions
- Version 1, 2023-01-16, Research Square
- Published version: Scientific Reports, 13 (1), 1.
This publication has 29 references indexed in Scilit:
- Transmembrane TNF-alpha promotes chemoresistance in breast cancer cellsOncogene, 2018
- The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasisNature Communications, 2017
- MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic CancerCancer Cell, 2017
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategiesThe Lancet, 2017
- SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung CancerClinical Cancer Research, 2016
- RETRACTED ARTICLE: SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironmentOncogene, 2016
- Src/STAT3‐dependent heme oxygenase‐1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagyCancer Science, 2015
- Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancerOncogene, 2015
- IKK-dependent, NF-κB-independent control of autophagic gene expressionOncogene, 2010
- Differential effects of chemotherapeutic agents on the Bcl‐2/Bax apoptosis pathway in human breast cancer cell line MCF‐7Breast Cancer Research and Treatment, 1999